Extracellular ATP and ADP mediate diverse physiological responses in mammalian cells, in part through the activation of G protein-coupled P 2 purinoceptors. The cloning and expression of cDNAs encoding several P 2 purinoceptor subtypes have enabled rapid advances in our understanding of the structural and functional properties of these receptors. The current report describes the isolation of a gene from a human genomic library that encodes a protein with the greatest similarity to the human P 2U purinoceptor, a subtype that is distinguished by its ability to be activated by uridine nucleotides as well as adenine nucleotides. When expressed in a mammalian cell line, this novel receptor is activated specifically by UTP and UDP but not by ATP and ADP. Activation of this uridine nucleotide receptor resulted in increased inositol phosphate formation and calcium mobilization. Fluorescence in situ hybridization revealed that the gene encoding the uridine nucleotide receptor is located in region q13 of the X chromosome. Dendrogram analysis of the G protein-coupled P 2 purinoceptors and the uridine nucleotide receptor indicates that these receptors belong to a family that may be more aptly named nucleotide receptors.
Nucleotides comprise one of the most recently recognized groups of compounds that function as extracellular signaling molecules (1) . Among the nucleotide family, ATP is the only established neurotransmitter/hormone. Recent articles have reported the cloning of the cDNAs and the predicted amino acid sequences for a variety of P 2 purinoceptors, including the G protein-coupled P 2U receptor, where UTP and ATP are equally efficacious, and the P 2Y receptors, where ATP, but not UTP, is active (reviewed in Ref. 2) . Pharmacological and structural data indicate that the G protein-coupled P 2 purinoceptors consist of several related but clearly distinct subtypes within the GPCR 1 superfamily. We report herein the isolation of a human gene, intronless within its coding region, that encodes a protein with a predicted structure characteristic of GPCRs and a sequence most similar to the P 2U purinoceptor. The results of functional studies indicate that the expressed protein encoded by the newly cloned DNA is a uridine nucleotide receptor. Human astrocytoma (1321N1) cells were obtained from M. L. Toews (University of Nebraska, Omaha, NE), and a clonal line that exhibited no nucleotide receptor activity was selected. PA317 cells (CRL9078) were purchased from the American Type Culture Collection (Rockville, MD). G418 (Geneticin) and the BioNick labeling kit were purchased from Life Technologies, Inc. All other chemicals were purchased from Sigma.
PCR and Genomic Library Screening-Human genomic DNA was amplified by PCR using degenerate oligonucleotides based on the sequences encoding transmembrane domains 3 (P1, 5Ј-GT(G/C)AT-GAG(T/C)G(T/C)(G/A/C)GACCG(C/A)TA) and 7 (P2, 5Ј-GGGGTT(G/ C)AGGCA(G/C)(G/C)(T/A)GTT) that are conserved between the opioidand somatostatin-like GPCRs 7 and 8 (3), the opioid receptors, and the somatostatin receptors. The PCR conditions were as follows: denaturation at 94°C for 3 min, annealing at 42°C for 2 min, and extension at 72°C for 3 min, for 30 cycles, followed by a 7-min extension at 72°C (4). The resultant amplified DNA was extracted with phenol/chloroform, precipitated with ethanol, and electrophoresed on a low melting point agarose gel. A band in the 500-base pair range was excised, ligated into the EcoRV site of pBluescript SK(Ϫ) (Stratagene, La Jolla, CA), and sequenced as described previously (4) . A clone that shared identity with several GPCRs was isolated, labeled with [ 32 P]dCTP, and used to screen a human EMBL3 SP6/T7 genomic library (Clontech, Palo Alto, CA). A positive clone (clone 49) was isolated, and DNA was prepared from the purified plaque, restriction enzyme-digested, electrophoresed on an agarose gel, transferred to nylon membrane, and probed with the PCR product as described previously (4) .
Receptor Expression and Function-Clone 49 was inserted between the EcoRI and XhoI sites of the retroviral expression plasmid, pLXSN. The recombinant plasmid, pLXSNc49, was then transfected into PA317 amphotrophic packaging cells for production of the viral vector, LXSNc49, as described previously (5) . Human 1321N1 astrocytoma cells were infected with LXSNc49 or LXSN control vector (for 24 h with 4 g/ml Polybrene) and selected for neomycin resistance with 1.5 mg/ml G418. To assay for receptor activity, nucleotide-stimulated changes in the concentration of intracellular free calcium ([Ca 2ϩ ] i ) were measured by dual excitation spectrofluorometric analysis of cell suspensions loaded with fura-2 as described previously (6) . The calcium mobilization experiments shown were performed in HEPES-buffered saline (pH 7.4) containing 1 mM CaCl 2 , 1 mM MgCl 2 , and 1 mM glucose. Changes in intracellular total inositol phosphates (7) and in cyclic AMP production (8) were determined by methods described previously.
Chromosomal Localization-Lymphocytes isolated from human cord blood were cultured in ␣-minimum essential medium supplemented with 10% (v/v) fetal calf serum and phytohemagglutinin at 37°C for 68 -72 h. The lymphocyte cultures were treated with 0.18 mg/ml bro-* Funding for this work was provided by the Addiction Research Foundation of Ontario, the Medical Research Council of Canada, the Cystic Fibrosis Foundation, the University of Missouri Food for the 21st Century Program, and National Institutes of Health Grants DA07223, DE07389, and GM36887. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. modeoxyuridine to synchronize the cell population. The synchronized cells were washed three times with serum-free medium to release them from G o and recultured at 37°C for 6 h in ␣-minimum essential medium containing 2.5 g/ml thymidine. Cells were harvested, and metaphase spread chromosome slides were made by using standard procedures including hypotonic treatment, fixation, and air drying. The clone 49 phage was biotinylated with dATP using the BRL BioNick labeling kit (15°C, 2 h) and used for fluorescence in situ hybridization (FISH) detection as described previously (9 -11). Briefly, slides were baked at 55°C for 1 h. After RNase A treatment, the samples were denatured in 70% (v/v) formamide in 2 ϫ standard saline citrate for 2 min at 70°C, followed by dehydration with ethanol. Probes were denatured at 75°C for 5 min in a hybridization mix consisting of 50% (v/v) formamide, 10% (w/v) dextran sulfate, and human Cot I DNA (Life Technologies, Inc.) and prehybridized for 15 min at 37°C to block repetitive sequences. Probes were loaded on the denatured chromosome slides. After overnight hybridization, slides were washed, and the FISH signal was amplified and detected as described previously (10) . FISH signals and the DAPI banding pattern were recorded separately by taking photographs, and the assignment of the FISH mapping data with chromosomal bands was achieved by superimposing FISH signals with DAPIstained chromosomes (11).
RESULTS AND DISCUSSION
Genes encoding novel GPCRs were detected by PCR amplification of human genomic DNA using degenerate oligonucleotides based on the sequences encoding transmembrane spanning domains 3 and 7 of the opioid receptors, somatostatin receptors, and the related GPCRs 7 and 8. A DNA fragment was isolated and used to screen a human genomic library to obtain a full-length clone. A single phage clone (clone 49) was isolated and, following restriction enzyme digestion and Southern analyses, a 2.5-kilobase pair SacI fragment was isolated, subcloned into pBluescript, and sequenced. This genomic clone contained an intronless open reading frame of 1095 base pairs encoding a protein of 365 amino acids with features characteristic of GPCRs. The encoded protein has the greatest overall identity with the human P 2U purinoceptor (54%), the rat P 2Y purinoceptor (33%), and the human delta opioid receptor (25%). The greatest degree of amino acid identity occurred within the putative seven-transmembrane domains where it demon- c, human P 2Y , Z49205; d, human P 2U , U07225; e, mouse P 2U , L14751; f, mouse P 2Y , U22829; g, human uridine nucleotide receptor, U40223; h, rat P 2U , U09402; i, rat P 2Y , U22830; j, turkey P 2Y , U09842. The tree-fitting index was 0.24, with values less than 1.0 considered a good fit.
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strated 74% identity with the P 2U receptor, 48% with the P 2Y receptor, and 35% with the human delta opioid receptor. The alignment of the protein encoded by clone 49 with these various receptors is shown in Fig. 1 . The predicted amino acid sequence of the protein encoded by clone 49 suggests no amino-terminal glycosylation sites, a single consensus site for protein kinase A phosphorylation between TMDs 5 and 6, and a cysteine residue required for post-translational modification by palmitoylation in the carboxyl-terminal tail.
To determine whether or not phage clone 49 encodes a functional nucleotide receptor, the DNA was inserted into the retroviral vector, pLXSN, and the construct was stably expressed in 1321N1 cells. Application of extracellular UTP to these cells caused a rapid increase in [Ca 2ϩ ] i , followed by a gradual decline to slightly above the prestimulation level when the cells were incubated in Ca 2ϩ -containing medium (Fig. 2A) . In Ca 2ϩ -depleted medium, UTP caused a rapid increase in [Ca 2ϩ ] i that was of the same magnitude as the response in Ca 2ϩ -containing medium but which returned quickly to the prestimulation level. As also shown in Fig. 2A , extracellular ATP did not increase [Ca 2ϩ ] i . Concentration-response curves indicated that UTP was approximately 100-fold more potent than UDP and the UTP analog 5-Br-UTP (Fig. 2B) . ITP and dTTP, at concentrations Ն100 M, caused modest increases in [Ca 2ϩ ] i (Fig. 2B) , whereas other nucleotides and nucleosides, including GTP, CTP, ADP, UMP, and uridine, had no effect. This agonist specificity profile is distinctly different from that of any reported P 2 purinoceptor and indicates that clone 49 encodes a uridine nucleotide receptor (UNR). It is also important to note that the pharmacological profile of the expressed clone 49 receptor (Fig. 2B) is different from that reported for the uridine nucleotide-selective receptor identified in functional studies in rat C6 -2B cells (12) , which exhibits a rank order potency of UDP Ͼ 5-Br-UTP Ͼ UTP. Whether this difference is indicative of species variations in agonist responsiveness or the existence of multiple UNR subtypes awaits further investigation.
The inability of ATP to increase [Ca 2ϩ ] i in 1321N1 cells expressing the UNR raised the question of whether ATP might act as an antagonist, similar to its effect on ADP activation of platelets (13) . We found that a 10-fold or greater molar excess of ATP inhibited the increase in [Ca 2ϩ ] i induced by UTP. In a representative experiment, the increase in [Ca 2ϩ ] i obtained with 0.5 M UTP was reduced by about 75% in the presence of 100 M ATP. However, this effect was not unique for ATP since high concentrations of GTP and CTP also inhibited UTP-induced increases in [Ca 2ϩ ] i . We are currently investigating the nature of this inhibitory effect.
The mobilization of intracellular Ca 2ϩ mediated by the UNR is accompanied by an increase in the hydrolysis of polyphosphoinositides. In a representative experiment, UTP (1 M) increased the level of total [ 3 H]inositol phosphates from a basal value of 2880 to 3807 cpm, whereas the value with 100 M ATP was 2923 cpm. In addition, inclusion of 100 M ATP inhibited the response to 1 M UTP by about 80% (3083 cpm), consistent with the ability of ATP to block UTP-stimulated Ca 2ϩ mobilization. The UNR does not appear to be coupled to adenylyl cyclase, since application of UTP to UNR-expressing cells did not cause an increase in cyclic AMP levels nor did UTP inhibit forskolin-stimulated cyclic AMP production (data not shown).
FISH analysis of metaphase spread chromosomes was used to identify the chromosomal location of clone 49. Under the conditions used, the hybridization efficiency of probe phage clone 49 was approximately 100%; of 100 mitotic figures checked, 99 showed signals on one pair of the chromosomes. By examining the DAPI banding pattern, the signal from probe phage clone 49 was assigned to the long arm of chromosome X. A more precise localization was obtained based on the summary from 10 photos of mitotic chromosomes probed with phage clone 49. Typical photographs of FISH and DAPI banding are shown in Fig. 3, A and B, respectively. An example of the mapping results is presented in Fig. 3C . These results indicate that the UNR gene is located on chromosome X in region q13.
The human UNR was aligned with the nine reported P 2 purinoceptor amino acid sequences, and a dendrogram was prepared with a phylogenetic tree-generating program (14) . The dendrogram (Fig. 4) confirms that the UNR is more related, in terms of primary structure, to the P 2U purinoceptor than it is to the P 2Y purinoceptor. In addition, the uridine nucleotide and P 2U receptors are more closely related than are the P 2U and P 2Y receptors. This suggests a common ancestor from which two receptor types arose, those using ATP as an agonist and those using both ATP and UTP, or UTP alone, as their agonist(s). Thus, nucleotide receptors may be a more suitable name for the family of receptors to which the UNR and the G protein-coupled P 2 purinoceptors belong.
